000			02391 a2200661 4500
005			20250515013107.0
264		0	_c20060526
008			200605s 0 0 eng d
022			_a1478-3223
024	7		_a10.1111/j.1478-3231.2005.01196.x _2doi
040			_aNLM _beng _cNLM
100	1		_aYu, Ming-Lung
245	0	0	_aA randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan. _h[electronic resource]
260			_bLiver international : official journal of the International Association for the Study of the Liver _cFeb 2006
300			_a73-81 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdiagnosis
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aLiver Function Tests
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMiddle Aged
650	0	4	_aPilot Projects
650	0	4	_aPolyethylene Glycols
650	0	4	_aProbability
650	0	4	_aROC Curve
650	0	4	_aRecombinant Proteins
650	0	4	_aReference Values
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aRisk Assessment
650	0	4	_aSeverity of Illness Index
650	0	4	_aSingle-Blind Method
650	0	4	_aTaiwan
650	0	4	_aTreatment Outcome
700	1		_aDai, Chia-Yen
700	1		_aLin, Zu-Yau
700	1		_aLee, Li-Po
700	1		_aHou, Nei-Jen
700	1		_aHsieh, Ming-Yen
700	1		_aChen, Shinn-Cherng
700	1		_aHsieh, Ming-Yuh
700	1		_aWang, Liang-Yen
700	1		_aChang, Wen-Yu
700	1		_aChuang, Wan-Long
773	0		_tLiver international : official journal of the International Association for the Study of the Liver _gvol. 26 _gno. 1 _gp. 73-81
856	4	0	_uhttps://doi.org/10.1111/j.1478-3231.2005.01196.x _zAvailable from publisher's website
999			_c16036503 _d16036503